Released Mar 31, 2014, before the open
10-K filed Mar 31, 2014, 90 days after period end · 0001193125-14-122624
Q4 2013 · 10-K
Revenue$105.89M$105.89M −8.4% vs Q4 2012+15.3% vs Q3 2013
Net Income-$10.41M-$10.41M N/M vs Q4 2012N/M vs Q3 2013
EPS Diluted-$0.58-$0.58 N/M vs Q4 2012N/M vs Q3 2013
Gross Profit$71,763,000−19.2%
Operating Income-$10,079,000N/M
Operating Cash Flowderived$15,139,000N/M
Free Cash Flowderived$9,779,000N/M
Margins · derived
Gross margin67.8%−9.1 pt vs Q4 2012
Operating margin-9.5%−32.5 pt vs Q4 2012
Net margin-9.8%−29.7 pt vs Q4 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|
| Revenue | $105.89M | $115.61M | $118.64M | $143.80M |
| Net Income | -$10.41M | $22.95M | $7.89M | $7.96M |
| EPS Diluted | -$0.58 | $1.17 | $0.42 | $0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR